Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -84.80% is in line with its 5-year average of -86.32%, near the high end of its 5-year range (-279.96%–-32.06%).
As of the fiscal period ended Tuesday, June 30, 2026. 10.04% above its 12-month average of -94.27%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -84.80%.
RETURN ON EQUITY (ROE)
-84.80%
RETURN ON EQUITY (ROE) AVG TTM
-94.27%
RETURN ON EQUITY (ROE) AVG 3Y
-72.90%
RETURN ON EQUITY (ROE) AVG 5Y
-86.32%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+10.04%
CURRENT VS 3Y AVG
-16.33%
CURRENT VS 5Y AVG
+1.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 753 covered companies
CURRENT VS SECTOR MEDIAN
-101.86%
vs the sector median at left
Yarrow Bioscience Inc
Market Cap
$174.27M
Return on Equity (ROE)
-84.80%
TTM Avg
-94.27%
3Y Avg
-72.90%
5Y Avg
-86.32%
Market Cap
$173.76M
Return on Equity (ROE)
-54.27%
TTM Avg
-50.07%
3Y Avg
-62.91%
5Y Avg
-60.87%
Market Cap
$172.42M
Return on Equity (ROE)
-31.32%
TTM Avg
4.38%
3Y Avg
4.09%
5Y Avg
11.26%
Market Cap
$171.13M
Return on Equity (ROE)
-116.42%
TTM Avg
-18.43%
3Y Avg
-136.68%
5Y Avg
-137.61%
Market Cap
$169.53M
Return on Equity (ROE)
-19.01%
TTM Avg
-54.50%
3Y Avg
-75.60%
5Y Avg
-59.28%
Market Cap
$179.26M
Return on Equity (ROE)
55.08%
TTM Avg
9.52%
3Y Avg
-0.62%
5Y Avg
-4.34%
Market Cap
$168.92M
Return on Equity (ROE)
-56.61%
TTM Avg
-75.88%
3Y Avg
-88.15%
5Y Avg
-30.55%
Market Cap
$179.75M
Return on Equity (ROE)
-44.23%
TTM Avg
-36.61%
3Y Avg
-30.86%
5Y Avg
-42.66%
Market Cap
$168.10M
Return on Equity (ROE)
-7104.24%
TTM Avg
-166.54%
3Y Avg
-137.65%
5Y Avg
-112.46%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Yarrow Bioscience Inc (YARW) | $174.27M | -84.80% | -94.27% | -72.90% | -86.32% |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | -54.27% | -50.07% | -62.91% | -60.87% |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | -31.32% | 4.38% | 4.09% | 11.26% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -116.42% | -18.43% | -136.68% | -137.61% |
| Journey Medical Corporation (DERM)vs › | $169.53M | -19.01% | -54.50% | -75.60% | -59.28% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $179.26M | 55.08% | 9.52% | -0.62% | -4.34% |
| MediWound Ltd. (MDWD)vs › | $168.92M | -56.61% | -75.88% | -88.15% | -30.55% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | -44.23% | -36.61% | -30.86% | -42.66% |
| Cue Biopharma, Inc. (CUE)vs › | $168.10M | -7104.24% | -166.54% | -137.65% | -112.46% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | -21.57% | -470.91% | -299.18% | -180.76% |
ROE
-84.8%
ROA
-79.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -84.80% |
| 2026-03-31 | -87.09% |
| 2025-12-31 | -95.38% |
| 2025-09-30 | -104.92% |
| 2025-06-30 | -99.13% |
| 2025-03-31 | -95.61% |
| 2024-12-31 | -76.48% |
| 2024-09-30 | -53.51% |
| 2024-06-30 | -37.97% |
| 2024-03-31 | -34.88% |
| 2023-12-31 | -32.06% |
| 2023-09-30 | -279.96% |
| 2023-06-30 | -203.13% |
| 2023-03-31 | -126.75% |
| 2022-12-31 | -74.39% |
| 2022-09-30 | -61.98% |
| 2022-06-30 | -75.81% |
| 2022-03-31 | -86.32% |
| 2021-12-31 | -150.77% |
| 2021-09-30 | -144.24% |
| 2021-06-30 | -117.99% |
| 2021-03-31 | -253.91% |
| 2020-12-31 | -681.64% |
| 2020-09-30 | -512.73% |
| 2020-06-30 | -343.96% |
| 2020-03-31 | -136.71% |
| 2019-12-31 | -107.58% |
| 2019-09-30 | -80.23% |
| 2019-06-30 | -64.39% |
| 2019-03-31 | -49.87% |
| 2018-12-31 | -39.46% |
| 2018-09-30 | -29.36% |
| 2018-06-30 | -24.31% |
| 2018-03-31 | -21.88% |
